Yang, X., Ma, X., Zhao, T., Croucher, D. R., Nguyen, E. V., Clark, K. C., Hu, C., Latham, S. L., Bayly-Jones, C., Nguyen, B. V., Budnar, S., Shin, S., Nguyen, L. K., Cotton, T. R., Chüeh, A. C., Sian, T. C. C. L. K., Stratton, M. M., Ellisdon, A. M., Daly, R. J. (2025). Activation of CAMK2 by pseudokinase PEAK1 represents a targetable pathway in triple negative breast cancer. Nature Communications. https://doi.org/10.1038/s41467-025-57046-8